Drug Pipeline Success: Positive clinical trial results for new drugs typically drive the stock price higher, while failures can cause significant declines. Regulatory Approvals: Approval or rejection of key drugs by regulatory bodies like the FDA directly impacts revenue projections and investor sentiment. Competition: New drug launches or competitive pricing strategies from rivals can erode AstraZeneca's market share and affect its stock price. Patent Expirations: When patents expire on key drugs, generic versions can enter the market, leading to lower sales and impacting revenue. Macroeconomic Factors: Overall economic conditions, including interest rates and inflation, can influence investor appetite for pharmaceutical stocks. Market Sentiment: General investor optimism or pessimism toward the pharmaceutical industry or the stock market as a whole can affect the stock. Company Financial Performance: Revenue growth, profitability, and earnings per share (EPS) strongly influence investor confidence and stock valuation. Mergers and Acquisitions: Announcements of mergers or acquisitions involving AstraZeneca can create uncertainty or excitement, affecting stock prices. Dividend Policy: Changes in dividend payouts or dividend yields can attract or deter investors, impacting stock demand and price. Geopolitical Risks: Global events and political instability can impact supply chains and market access, influencing AstraZeneca's stock.